Sign In
Buy NVRO
$5.84
+0 (+0%)
At Close: Jul 01, 2025
Global Neurology Devices Market (2019 to 2025) - Featuring LivaNova, Magstim & Medtronic Among Others - ResearchAndMarkets.com
12:00am, Monday, 10'th Aug 2020
The
Nevro (NVRO) Q2 Loss Narrower than Expected, Revenues Beat
11:20am, Friday, 07'th Aug 2020
Nevro's (NVRO) domestic and international revenues declined on a year-over-year basis in Q2.
Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference
11:00am, Friday, 07'th Aug 2020
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chai
Is Nevro Corp. (NYSE:NVRO) Potentially Undervalued?
05:24pm, Thursday, 06'th Aug 2020
Nevro Corp. (NYSE:NVRO), might not be a large cap stock, but it led the NYSE gainers with a relatively large price...
Nevro (NVRO) Reports Q2 Loss, Tops Revenue Estimates
09:45pm, Wednesday, 05'th Aug 2020
Nevro (NVRO) delivered earnings and revenue surprises of 26.67% and 36.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Nevro Announces Second Quarter 2020 Financial Results
08:10pm, Wednesday, 05'th Aug 2020
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its financial results for the second
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Why Nevro Corp (NVRO) Stock is a Compelling Investment Case
02:54pm, Friday, 31'st Jul 2020
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Small-Cap Growth Fund posted a return of 34.59% for the quarter, outperforming its benchmark, t
Nevro (NVRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:33pm, Wednesday, 29'th Jul 2020
Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nevro to Report Second Quarter 2020 Financial Results
11:00am, Monday, 20'th Jul 2020
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its fi
3 CEFs For A Crisis Investing Dividend Strategy
12:00am, Monday, 20'th Jul 2020
Stocks Analysis by Contrarian Outlook (Michael Foster) covering: S&P 500, Microsoft Corporation, Apple Inc, Amazon.com Inc. Read Contrarian Outlook (Michael Foster)'s latest article on Investing.com
Did Hedge Funds Make The Right Call On Nevro Corp (NVRO) ?
08:17pm, Monday, 13'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
12:46pm, Friday, 10'th Jul 2020
Investor confidence is high on Nevro (NVRO), thanks to solid prospects
